Biological Information
Background Information:
CDC42BPB (CDC42 binding protein kinase beta) is another member of the rho family and triggers the formation of actin-based structure found at lamellipodia and filopodia. CDC42BPB plays an important role in determining mammalian cell morphology for the coordinated control of cell motility by members of the rho family of GTPases.
Family:
Kinase
Sub Family:
AGC
Class:
Protein Ser/Thr
Protein Name:
MRCKbeta
Uniprot Number:
Q9Y5S2
Protein Aliases:
CDC42-binding protein kinase beta|CDC42BP-beta|DMPK-like beta|Myotonic dystrophy kinase-related CDC42-binding kinase beta|MRCK beta|Myotonic dystrophy protein kinase-like beta
Gene Name:
CDC42BPB
Gene ID:
9578
Gene Aliases:
MRCKB|KIAA1124
Accession Number:
NM_006035
Organism:
Human
Construct Details:
1-473 recombinant
Assay Information
Assay Type:
Biochemical
Assay Sub Type:
Enzymatic
Functional Mode:
Antagonist
Detection Method:
Radiometric
Measured Response:
Scintillation
Testing Information
Procedure Summary:
MRCKb (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 100 µM KKRNRTLTV, 10 mM MgAcetate and [g- 33P]-ATP (specific activity and concentration as required). The reaction is initiated by the addition of the Mg/ATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of phosphoric acid to a concentration of 0.5%. An aliquot of the reaction is then spotted onto a filter and washed four times for 4 minutes in 0.425% phosphoric acid and once in methanol prior to drying and scintillation counting.
Substrate:
100 uM KKRNRTLTV
Tracer:
33P
ATP Concentration:
[ATP]= 10µM (Km= 5µM )
Incubation:
40 min at Room temperature
Control Inhibitor:
Staurosporine
Test Sample Requirements:
Please provide compounds dissolved in 100% DMSO (PBS or HBSS prohibited).
Stock solution should be ≥50× the final assay concentration (a 10 mM stock is also acceptable).
Required volume:
– <60 kinase assays: 120 µL of 50× stock
– ≥60 assays: 420 µL of 50× stock
If you supply 10 mM stocks or powder (pre-weighed), we will apply the appropriate conversion.
For batches of ~50 compounds supplied as solids, the TAT will be extended.
Minimum Order Quantity:
2
Turnaround Time
Standard:
6 Business Days
Service Scheduling Note:
Assay is run on a weekly schedule beginning on Friday. Compounds and purchase order must be received on or before 13:00 CET Thursday for the order to be included on the service run that begins on Friday of the same week.
Reference Compound Data
Clinical Relevance
Therapeutic Area:
Oncology/Immuno-Oncology
Adverse / Beneficial Action:
Inhibition of CDC42BPB may be useful in the treatment of certain inflammatory conditions.
Additional Information
Brand:
LeadHunter
Testing Location:
KP - France - Celle L'Evescault
RELATED SOLUTIONS